Native T1 Mapping in Transthyretin Amyloidosis
Author(s) -
Marianna Fontana,
Sanjay M Banypersad,
Thomas A. Treibel,
Viviana Maestrini,
Daniel Sado,
Steven K White,
Silvia Pica,
Silvia Castelletti,
Stefan K. Piechnik,
Matthew D. Robson,
Janet A. Gilbertson,
Dorota Rowczenio,
David F. Hutt,
Helen J. Lachmann,
Ashutosh D. Wechalekar,
Carol Whelan,
Julian D. Gillmore,
Philip N. Hawkins,
James Moon
Publication year - 2014
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2013.10.008
Subject(s) - transthyretin , amyloidosis , medicine , cardiac amyloidosis , amyloid (mycology) , cardiomyopathy , gastroenterology , al amyloidosis , cardiology , restrictive cardiomyopathy , heart failure , pathology , antibody , immunoglobulin light chain , immunology
The aims of the study were to explore the ability of native myocardial T1 mapping by cardiac magnetic resonance to: 1) detect cardiac involvement in patients with transthyretin amyloidosis (ATTR amyloidosis); 2) track the cardiac amyloid burden; and 3) detect early disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom